Transcept Pharmaceuticals (TSPT)
Transcept Pharmaceuticals SG&A Expense: 2.784M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TSPT SG&A Expense Rankings
| Overall | 87th percentile | 530 of 4195 |
| Sector | 74th percentile | 122 of 487 in Healthcare |
| Industry | 61st percentile | 59 of 154 in Biotechnology |
TSPT SG&A Expense Range, Past 5 Years
| Minimum | -7.593M | Dec 2007 |
| Maximum | 5.384M | Jun 2007 |
| Average | 2.570M |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
You may also be interested in these TSPT related companies
TSPT News
$TSPT http://stks.co/40nB Got a quick 10% off TSPT from May 22 watchlist!
about 3 days ago by RalfKaiser
about 3 days ago by RalfKaiser
$TSPT Mentioned more than normal on StockTwits - Currently at 5 x average daily social activity
about 7 days ago by TradeIdeasQuant
about 7 days ago by TradeIdeasQuant
RT @HighGrowthFinancial $TSPT Breakout, been posting since down .6% good looking out brother easy money
about 7 days ago by Newbie_Trader
about 7 days ago by Newbie_Trader
@fhmmax $ARNA you are right. Found it on here! "
$TSPT seeks $40.5M in public offering to advance OCD candidate TO-2061, shares slide 14%"
about 17 days ago by BiopharmaPro
about 17 days ago by BiopharmaPro
$TSPT Mentioned more than normal on StockTwits - Currently at 10 x average daily social activity
about 17 days ago by TradeIdeasQuant
about 17 days ago by TradeIdeasQuant
@fhmmax $ARNA dropped on $TSPT doing a stock dilution? did they say how many shares and at what price when it dropped?
about 17 days ago by BiopharmaPro
about 17 days ago by BiopharmaPro
$AMRN $TSPT raised to outperfom http://stks.co/3pO3{372423ee-fd5e-490b-8081-ee1361c10014}
about 17 days ago by fhmmax
about 17 days ago by fhmmax
Listen to $TSPT Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3ono
about 18 days ago by earningscast
about 18 days ago by earningscast
Transcept Pharmaceuticals, (TSPT) Posts Wider than Expected Q1 Loss of 37c/Share
May 14, 4:03PM Street Insider
May 14, 4:03PM Street Insider
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 09, 6:58AM PR Newswire
May 09, 6:58AM PR Newswire
$TSPT wonder why the secondary? the conference call implied Purdue as $$ Facility, not shareholders. Waitin for $7.50-80
about 25 days ago by HighGrowthFinancial
about 25 days ago by HighGrowthFinancial
Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
Apr 16, 4:35PM PR Newswire
Apr 16, 4:35PM PR Newswire
Transcept Pharmaceuticals Announces National Product Launch of Intermezzo® by Purdue Pharma L.P.
Apr 05, 6:38AM Benzinga
Apr 05, 6:38AM Benzinga
Transcept (TSPT) Reports New Dosages of Intermezzo Available for Prescription
Apr 05, 6:27AM Street Insider
Apr 05, 6:27AM Street Insider
Transcept Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Mar 14, 4:03PM PR Newswire
Mar 14, 4:03PM PR Newswire
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 29, 8:03AM PR Newswire
Feb 29, 8:03AM PR Newswire
JMP Securities Starts Transcept Pharmaceuticals (TSPT) at Market Outperform
Feb 10, 8:22AM Street Insider
Feb 10, 8:22AM Street Insider
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 07, 8:05AM PR Newswire
Feb 07, 8:05AM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TSPT | 7.08 | -0.02 | -0.28% | 98.69M |
| TSON | 2.93 | -0.05 | -1.68% | 81.20M |
| TSO | 22.12 | -1.09 | -4.70% | 3.265B |
| TSM | 13.73 | -0.20 | -1.44% | 72.20B |
| TNB | 71.99 | +0.00 | +0.00% | 3.758B |
| TNAV | 6.01 | +0.20 | +3.44% | 241.81M |
| TNA | 47.26 | -0.31 | -0.65% | |
| TMX | 15.33 | +0.00 | +0.00% | |
| TMS | 11.10 | -0.37 | -3.23% | |
| TMP | 36.61 | +0.01 | +0.03% | 408.46M |